- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Top 5 AJMC® Articles of September 2018
Here are the top 5 articles for the month of September.
Transcript:
Hi, I’m Jaime Rosenberg for The American Journal of Managed Care®. Here are the top 5 articles for the month of September.
Number 5: An analysis from the Urban Institute found that health insurance coverage gains created by the Affordable Care Act caused the number of uninsured Americans to fall from 17% in 2013 to 10% in 2016.
Number 4: More than half of Americans misused prescription drugs in 2017. While the rate remains unchanged from 2016, there was an observed shift from prescription opioids to other drugs and dangerous drug combinations
Number 3: GlaxoSmithKline’s mepolizumab, marketed as Nucala, is superior to reslizumab and benralizumab for the treatment of eosinophilic asthma, a severe form of asthma that doesn’t respond well to corticosteroids, even at high doses.
Number 2: Researchers have discovered a new subtype of multiple sclerosis that has neuronal loss but no demyelination of the brain’s white matter, suggesting that demyelination and neuronal degeneration occur independently.
Number 1: A study looking at the toxic effects of cancer immunotherapy concluded that the incidence and timing of rare and fatal side effects from immune checkpoint inhibitors remain very low for patients with advanced cancer and should not keep patients from using the therapies.
To read all of these articles and more, visit AJMC.com
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
